Inoviq Ltd (AU:IIQ) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
INOVIQ Limited has achieved a significant breakthrough in breast cancer treatment by successfully developing exosome-based therapeutics that target and kill cancer cells with enhanced precision. These engineered exosomes, derived from natural killer cells, demonstrated a promising ability to kill a substantial percentage of aggressive breast cancer cells, showcasing potential for future clinical applications. The company plans to advance this technology through further studies, aiming to refine and optimize its therapeutic efficacy.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
